Pitcairn Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.95M Buy
3,293
+176
+6% +$180K 0.43% 36
2026
Q1
$3.35M Sell
3,117
-800
-20% -$811K 0.31% 41
2025
Q4
$4.21M Buy
+3,917
New +$3.75M 0.38% 36

Other funds holding LLY

Pitcairn Wealth Advisors's LLY Position: Q2 2026 in Review

Pitcairn Wealth Advisors increased its Eli Lilly (LLY) stake by 5.6% in Q2 2026, buying an estimated $180K and bringing the position to 3,293 shares worth $3.95M. The position accounts for 0.43% of the portfolio, ranked #36.

Pitcairn Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.21M in Q4 2025. 4,612 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pitcairn Wealth Advisors held 3,293 shares of Eli Lilly worth $3.95M as of Q2 2026.
  • Pitcairn Wealth Advisors bought 176 Eli Lilly shares in Q2 2026, an estimated $180K.
  • Eli Lilly made up 0.43% of Pitcairn Wealth Advisors's portfolio in Q2 2026, its #36 holding.
  • Pitcairn Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Pitcairn Wealth Advisors's Eli Lilly position peaked at $4.21M in Q4 2025.
  • 4,612 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pitcairn Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.